New Jersey Judge Asked to Approve $35 Million Settlement in Pfizer Lipitor Antitrust Case

End-payor plaintiffs have requested final approval from a New Jersey federal judge for a $35 million settlement to resolve their antitrust claims against Pfizer over the cholesterol medication Lipitor. The proposed agreement seeks to address allegations that Pfizer engaged in anti-competitive practices that hindered generic versions of the drug from entering the market, thus inflating prices. For further details, you can read the original piece here.